BAKER AVENUE ASSET MANAGEMENT, LP – Vertex Pharmaceuticals Incorporated Transaction History
BAKER AVENUE ASSET MANAGEMENT, LP portfolio value:
$498,000
portfolio value
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | 0.00% | 1.71K shares | 498K | $289.54 | 1.71K |
Q1 2021 | share | Decrease | -100.00% | -2.23K shares | -528K | $214.89 | 0 |
Q4 2020 | share | Decrease | -61.23% | -3.53K shares | -1.04M | $236.34 | 2.23K |
Q3 2020 | share | Increase | +13.29% | 677 shares | 91K | $272.12 | 5.77K |
Q2 2020 | share | Decrease | -6.10% | -331 shares | 188K | $290.31 | 5.09K |
Q1 2020 | share | Decrease | -9.90% | -596 shares | -27K | $237.95 | 5.42K |
Q4 2019 | share | Decrease | -21.94% | -1.69K shares | 11K | $218.95 | 6.02K |
Q3 2019 | share | Increase | +7.51% | 539 shares | -8K | $169.42 | 7.71K |
Q2 2019 | share | Increase | +3.48% | 241 shares | 40K | $183.38 | 7.17K |
Q1 2019 | share | Increase | 0.00% | 6.93K shares | 1.27M | $183.95 | 6.93K |
Q4 2016 | share | Decrease | -100.00% | -5.57K shares | -486K | $73.67 | 0 |
Q3 2016 | share | Increase | 0.00% | 5.57K shares | 486K | $87.21 | 5.57K |